CCL3 and neoplasm: We therefore generated remodelled TCM (rTCM) supplemented with RANTES and MIP-1α as a proof-of-concept to determine whether targeting these chemokine receptor-ligand pairs may be a viable option to increase NK cell migration towards the soluble chemotactic signals of the tumour.